You appear to be offline. Some data may be unavailable until your connection is restored.
DVA
StockDaVita Inc
Price data not available
Description
DaVita Inc. is a healthcare company that delivers kidney dialysis and related care services, operating outpatient dialysis centers, home‑based dialysis, hospital inpatient dialysis and associated laboratory and care‑management offerings. It focuses on patients with end‑stage renal disease and chronic kidney disease, providing both hemodialysis and peritoneal dialysis within an integrated kidney‑care model. The firm belongs to the healthcare sector, specifically the kidney‑care and dialysis industry. DaVita is one of the two largest dialysis providers in the United States, commanding roughly a third of the U.S. dialysis market and operating a nationwide network of more than 2,600 outpatient centers along with an international footprint. Its business model emphasizes scale, physician partnerships, and value‑based care contracts to support patient treatment continuity.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q4 FY26 | Jan 25, 2027 (est.) | — |
| Q3 FY26 | Oct 29, 2026 | $3.82 |
| Q2 FY26 | Aug 4, 2026 | $4.02 |
| Q1 FY26 | May 5, 2026 | $2.87 |
| Q4 FY25 | Feb 2, 2026 | $3.40 |
Stay ahead of DVA earnings
Get reminders ahead of DVA's next earnings report, so you always know when results are coming.